G&E Herbal Biotechnology Co., Ltd. (4911.TWO)
TWD 49.65
(0.3%)
TWD 49.65
(0.3%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 119.86 Million TWD | 30.37% |
| 2022 | 91.94 Million TWD | 959.34% |
| 2021 | 8.67 Million TWD | 3.47% |
| 2020 | 8.38 Million TWD | -31.35% |
| 2019 | 12.21 Million TWD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 100.21 Million TWD | 2.92% |
| 2024 Q1 | 97.36 Million TWD | -18.76% |
| 2023 Q1 | 67.54 Million TWD | 33170.94% |
| 2023 FY | 119.86 Million TWD | 30.37% |
| 2023 Q4 | 119.86 Million TWD | 219.76% |
| 2023 Q3 | 37.48 Million TWD | -24.52% |
| 2023 Q2 | 49.66 Million TWD | -26.47% |
| 2022 Q4 | 203 Thousand TWD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 583.48 Million TWD | 79.458% |
| Level Biotechnology Inc. | 273.2 Million TWD | 56.128% |
| Sagittarius Life Science Corp | 137.82 Million TWD | 13.034% |
| NeoCore Technology Co., Ltd. | 197.47 Million TWD | 39.302% |
| TaiMed Biologics Inc. | 1.32 Billion TWD | 90.973% |
| GlycoNex Incorporation | 276.39 Million TWD | 56.635% |
| GeneReach Biotechnology Corp. | 313.7 Million TWD | 61.792% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 514.65 Million TWD | 76.71% |
| SynCore Biotechnology Co.,Ltd | 21.22 Million TWD | -464.685% |
| Genomics BioSci & Tech. Co.,Ltd. | 368.33 Million TWD | 67.459% |
| Visgeneer Inc. | 185.6 Million TWD | 35.422% |
| Mycenax Biotech Inc. | 1.32 Billion TWD | 90.942% |
| Sunmax Biotechnology Co., Ltd. | 732.98 Million TWD | 83.648% |
| Neith Corporation | 17.43 Million TWD | -587.547% |
| Medigen Vaccine Biologics Corporation | 2.24 Billion TWD | 94.664% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 6.61 Million TWD | -1711.121% |
| Enimmune corporation | 173.46 Million TWD | 30.902% |
| TaiRx, Inc. | 60.62 Million TWD | -97.707% |
| EirGenix Inc. | 1.14 Billion TWD | 89.533% |
| BioLASCO Taiwan Co., Ltd. | 111.98 Million TWD | -7.036% |
| Sunny Pharmtech Inc. | 512.43 Million TWD | 76.61% |
| Lin BioScience, Inc. | 167.73 Million TWD | 28.54% |
| BioGend Therapeutics Co., Ltd. | 93.71 Million TWD | -27.9% |
| Feng Chi Biotech Corp. | 63.03 Million TWD | -90.151% |
| Bio Preventive Medicine Corp. | 124.72 Million TWD | 3.904% |
| Lukas Biomedical Inc. | 161.05 Million TWD | 25.58% |
| RBC Bioscience Corporation | 513.08 Million TWD | 76.639% |
| BiOptic Inc. | 170.56 Million TWD | 29.727% |
| BRIM Biotechnology, Inc. | 42.15 Million TWD | -184.311% |
| Shine-On BioMedical Co.,Ltd. | 23.25 Million TWD | -415.416% |
| Great Novel Therapeutics Biotech & Medicals | 26.81 Million TWD | -347.022% |
| VBI | 21.25 Million TWD | -464.021% |
| CHO Pharma, Inc. | 110.83 Million TWD | -8.146% |
| Anti-Microbial Savior BioteQ Co., Ltd | 6.99 Million TWD | -1613.755% |
| Syngen Biotech Co.,Ltd. | 974.63 Million TWD | 87.702% |
| Advagene Biopharma Co., Ltd. | 7.97 Million TWD | -1403.512% |
| NaviFUS Corp. | 53.4 Million TWD | -124.453% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 481.48 Million TWD | 75.106% |
| Sinew Pharma Inc. | 39.71 Million TWD | -201.808% |
| Andros Pharmaceuticals Co.,Ltd | 58.03 Million TWD | -106.516% |
| Greenyn Biotechnology Co., Ltd | 364.47 Million TWD | 67.114% |
| Lumosa Therapeutics Co., Ltd. | 227.69 Million TWD | 47.359% |
| AP Biosciences Inc | 106.65 Million TWD | -12.386% |
| Medigen Biotechnology Corp. | 3.53 Billion TWD | 96.605% |
| 3D Global Biotech Inc. | 30.68 Million TWD | -290.665% |
| Pharmosa Biopharm Inc. | 195.99 Million TWD | 38.844% |
| Intech Biopharm Corporation | 1.54 Billion TWD | 92.233% |
| Oneness Biotech Co., Ltd. | 866.42 Million TWD | 86.166% |
| Eusol Biotech Co.,Ltd. | 9.27 Million TWD | -1192.152% |
| TWi Biotechnology, Inc. | 55.81 Million TWD | -114.753% |
| Ever Supreme Bio Technology Co., Ltd | 232.95 Million TWD | 48.549% |
| TCI GENE Inc. | 155.54 Million TWD | 22.943% |
| MegaPro Biomedical Co., Ltd | 25.5 Million TWD | -369.892% |
| Senhwa Biosciences, Inc. | 46.17 Million TWD | -159.578% |
| Taiwan Bio Therapeutics Co., Ltd | 328.47 Million TWD | 63.51% |
| NatureWise Biotech & Medicals Corporation | 64.88 Million TWD | -84.721% |
| PharmaEngine, Inc. | 91 Million TWD | -31.706% |
| Savior Lifetec Corporation | 457.95 Million TWD | 73.827% |
| TaiGen Biopharmaceuticals Holdings Limited | 110.94 Million TWD | -8.04% |
| OBI Pharma, Inc. | 650.44 Million TWD | 81.573% |
| Meribank Biotech Co., Ltd | 390.81 Million TWD | 69.331% |
| Acepodia, Inc. | 384.47 Million TWD | 68.825% |
| Caliway Biopharmaceuticals Co., Ltd. | 85.55 Million TWD | -40.1% |